Government faces price cut dilemma

Published: 2008-10-07 06:58:00

Updated: 2008-10-07 06:58:00

Now, the government faces a “dilemma’’ over whether to cut prices of pharmaceutical products through the so-called positive list system to evaluate the cost effectiveness of medicines, as the unilateral move might invite strong protest and criticism from the industry.

“The government needs to ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK